Preview

Complex Issues of Cardiovascular Diseases

Advanced search

LONG-TERM OUTCOMES OF ILIAC ARTERY BYPASS WITH OCCLUSION SUPERFICIAL FEMORAL ARTERY

https://doi.org/10.17802/2306-1278-2026-15-1-24-31

Abstract

Highlights

The effect of the occluded superficial femoral artery on the patency of the aorto-femoral baypass remains controversial, since, on the one hand, in the absence of patency of the femoral-popliteal segment arteries, vascular resistance in the proximal segment increases, on the other hand, a passable deep femoral artery is a good runoff.

 

Background. Aorto-femoral bypass surgery is the “gold standard” in the treatment of extended lesions of the iliac arteries, as well as femoral-popliteal bypass surgery for extended lesions of the SFA, however, open multilevel reconstruction is not always possible (severe comorbid background of the patient, lack of adequate outflow arteries), in this regard, it seems interesting to search for a less invasive method of restoring blood flow by SFA or restoration of blood flow along the DFA of the thigh as along the main collateral of the lower limb.

Aim. To compare the effectiveness of aorto-femoral bypass surgery with restoration of blood flow by DFA and aorto-femoral bypass surgery with extended endarterectomy from SFA

Methods. The study included 82 patients with atherosclerotic lesions of the iliac arteries and arteries of the femoral-popliteal segment. The patients are divided into 2 groups. Group 1 included patients who underwent aorto-femoral bypass surgery with restoration of blood flow through the HBA. The second group consisted of patients who underwent aorto-femoral bypass surgery with loop endarterectomy from PBA. The primary patency of the aorto-femoral shunt, freedom from amputation, freedom from reintervation, as well as long-term survival were evaluated.

Results. Technical success in both groups was 100%. In group 1, there were no cases of early thrombosis of the aorto-femoral shunt and death in the early postoperative period. There are also no cases of amputation. In the second group, 2 cases of thrombosis were registered in the early postoperative period. The 5-year patency of the aorto-femoral shunt was 97.1% in group 1 and 95.7 % in the second group (p = .389) Long–term freedom from amputation did not differ – in group 1 it was 97.1% by year 5 and 93.7% in the second group (p= .098) Long-term survival was higher in the second group, but the difference was not statistically significant (p = .237)

Conclusions. Restoration of blood flow through the deep artery of the thigh with aorto-femoral bypass surgery allows to stop the symptoms of ischemia. Endarterectomy from SFA is an effective and safe alternative to femoral-popliteal bypass surgery. In our research, SFA reocclusion did not lead to acute or critical ischemia, and in half of the cases, the violation of the patency of PBA was asymptomatic. Occluded SFA is not a risk factor for impaired patency of the aorto-femoral shunt in the long term. 

About the Authors

Alexander A. Oborin
Perm Regional Clinical Hospital
Russian Federation

Cardiovascular surgeon, Perm Regional Clinical Hospital, Perm, Russian Federation



Ildus S. Mukhamadeev
Perm Regional Clinical Hospital
Russian Federation

PhD, MD, Chef of the Department of Cardiovascular Surgery, Perm Regional Clinical Hospital, Perm, Russian Federation; 



Alexey S. Vronsky
Clinical Cardiology dispensary
Russian Federation

PhD, Chef of the Department of Cardiac Surgery, Clinical Cardiology dispensary, Perm, Russian Federation



References

1. Diehm N, Shang A, Silvestro A, и др. Association of Cardiovascular Risk Factors with Pattern of Lower Limb Atherosclerosis in 2659 Patients Undergoing Angioplasty. Eur J Vasc Endovasc Surg. 2006;31(1):59–63. doi:https://doi.org/10.1016/j.ejvs.2005.09.006

2. Aboyans V, Ricco J-B, Bartelink M-LEL, и др. Editor’s Choice - 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS). Eur J Vasc Endovasc Surg Off J Eur Soc Vasc Surg. 2018;55(3):305–368. doi:10.1016/j.ejvs.2017.07.018

3. Tanaka A, Sandhu HK, Perlick A, и др. Superficial Femoral Artery Occlusion Reduces Aortofemoral Bypass Graft Patency. Eur J Vasc Endovasc Surg. 2019;57(5):650–657. doi:10.1016/j.ejvs.2018.10.031

4. White CJ, Gray WA. Endovascular therapies for peripheral arterial disease: an evidence-based review. Circulation. 2007;116(19):2203–2215. doi:10.1161/CIRCULATIONAHA.106.621391

5. Ouriel K, DeWeese JA, Ricotta JJ, Green RM. Revascularization of the distal profunda femoris artery in the reconstructive treatment of aortoiliac occlusive disease. J Vasc Surg. 1987;6(3):217–220.

6. Taurino M, Persiani F, Ficarelli R, Filippi F, Dito R, Rizzo L. The Role of the Profundoplasty in the Modern Management of Patient with Peripheral Vascular Disease. Ann Vasc Surg. Published online 2017 г.:1–6. doi:10.1016/j.avsg.2017.05.018

7. Ito R, Kumada Y, Ishii H, и др. Clinical Outcomes after Isolated Infrapopliteal Revascularization in Hemodialysis Patients with Critical Limb Ischemia: Endovascular Therapy versus Bypass Surgery. J Atheroscler Thromb. 2018;25(9):799–807. doi:10.5551/jat.42648

8. Melillo E, Micheletti L, Nuti M, и др. Long-term clinical outcomes in critical limb ischemia--A retrospective study of 181 patients. Eur Rev Med Pharmacol Sci. 2016;20(3):502–508.

9. Okuno S, Iida O, Iida T, и др. Comparison of Clinical Outcomes between Endovascular Therapy with Self-Expandable Nitinol Stent and Femoral-Popliteal Bypass for Trans-Atlantic Inter-Society Consensus (TASC) II C and D Femoropopliteal Lesions. Ann Vasc Surg. Published online 2018 г. doi:10.1016/j.avsg.2018.09.024

10. Gk A, Cp T, Ambler GK, Twine CP. Graft type for femoro-popliteal bypass surgery ( Review ) SUMMARY OF FINDINGS FOR THE MAIN COMPARISON. Cochrane Database Syst Rev. 2018;2(2):CD001487. doi:10.1002/14651858.CD001487.pub3.www.cochranelibrary.com

11. Sharples A, Kay M, Sykes T, Fox A, Houghton A. Multilevel bypass grafting: Is it worth it? Ann Vasc Surg. 2014;28(7):1697–1702. doi:10.1016/j.avsg.2014.03.027

12. Benson JR, Mc MAJ, Whelen TJ, и др. Combined Aorto-iliac and Femoropopliteal Occlusive Disease : V Limitations of Total Aortofemoropopliteal Bypass nature of arteriosclerotic occlusive disease , disease has been successfully treated by treated with autologous bypass grafting Assistant Chief. Published online 1965 г.

13. Miyahara T, Shigematsu K, Nishiyama A, Hashimoto T, Hoshina K, Watanabe T. Long-Term Results of Combined Aortoiliac and Infrainguinal Arterial Reconstruction for the Treatment of Critical Limb Ischemia. Ann Vasc Dis. 2015;8(1):14–20. doi:10.3400/avd.oa.14-00119

14. Lee GC, Yang SS, Park KM, и др. Ten year outcomes after bypass surgery in aortoiliac occlusive disease. J Korean Surg Soc. 2012;82(6):365–369. doi:10.4174/jkss.2012.82.6.365

15. Kram HB, Veith FJ, Wengerter KR. Unilateral Aortofemoral Bypass : A Safe and Effective Option for the Treatment of Unilateral. 1991;162(August):1989–1992.

16. Lau H, Cheng SW. Long-term outcome of aortofemoral bypass for aortoiliac occlusive disease. Ann Acad Med Singapore. 2000;29(4):434–438.

17. Kudo T, Chandra FA, Ahn SS. Long-term outcomes and predictors of iliac angioplasty with selective stenting. J Vasc Surg. 2005;42(3):466–475. doi:10.1016/j.jvs.2005.05.002

18. Dalman RL, Taylor LMJ, Moneta GL, Yeager RA, Porter JM. Simultaneous operative repair of multilevel lower extremity occlusive disease. J Vasc Surg. 1991;13(2):211–221.

19. Marston WA, Davies SW, Armstrong B, и др. Natural history of limbs with arterial insufficiency and chronic ulceration treated without revascularization. J Vasc Surg. 2006;44(1):108–114. doi:10.1016/j.jvs.2006.03.026

20. Becker F, Robert-Ebadi H, Ricco J-B, и др. Chapter I: Definitions, epidemiology, clinical presentation and prognosis. Eur J Vasc Endovasc Surg Off J Eur Soc Vasc Surg. 2011;42 Suppl 2:S4-12. doi:10.1016/S1078-5884(11)60009-9

21. Brewster DC. Current controversies in the management of aortoiliac occlusive disease. J Vasc Surg. 1997;25(2):365–379. doi:10.1016/s0741-5214(97)70359-8

22. Sharma G, Scully RE, Shah SK, и др. Thirty-year trends in aortofemoral bypass for aortoiliac occlusive disease. J Vasc Surg. 2018;68(6):1796-1804.e2. doi:10.1016/j.jvs.2018.01.067

23. Mukhamadeev IS, Oborin AA, Danilov VN, Vronskiĭ AS. [Results of loop endarterectomy and femoropopliteal bypass grafting in TASC C and D lesions]. Angiol Sosud Khir. 2021;27(1):107–112. doi:10.33529/ANGIO2021120

24. Antoniou GA, Koutsias S, Antoniou SA, Giannoukas AD. Remote endarterectomy for long segment superficial femoral artery occlusive disease. A systematic review. Eur J Vasc Endovasc Surg Off J Eur Soc Vasc Surg. 2008;36(3):310–318. doi:10.1016/j.ejvs.2008.04.005

25. Galland RB, Whiteley MS, Gibson M, Simmons MJ, Torrie EP, Magee TR. Maintenance of patency following remote superficial femoral artery endarterectomy. Cardiovasc Surg. 2000;8(7):533–537. doi:10.1016/s0967-2109(00)00072-7

26. Devalia K, Magee TR, Galland RB. Remote superficial femoral endarterectomy: Long-term results. Eur J Vasc Endovasc Surg Off J Eur Soc Vasc Surg. 2006;31(3):262–265. doi:10.1016/j.ejvs.2005.10.019

27. Madiba TE, Mars M, Robbs J V. Aortobifemoral bypass in the presence of superficial femoral artery occlusion: does the profunda femoris artery provide adequate runoff? J R Coll Surg Edinb. 1998;43(5):310–313.

28.


Review

For citations:


Oborin A.A., Mukhamadeev I.S., Vronsky A.S. LONG-TERM OUTCOMES OF ILIAC ARTERY BYPASS WITH OCCLUSION SUPERFICIAL FEMORAL ARTERY. Complex Issues of Cardiovascular Diseases. 2026;15(1):24-31. (In Russ.) https://doi.org/10.17802/2306-1278-2026-15-1-24-31

Views: 217

JATS XML


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2306-1278 (Print)
ISSN 2587-9537 (Online)